Why SBIR Phase II recipients matter to technology investors
The Small Business Innovation Research program sets aside part of the extramural research budgets of large federal agencies for US small businesses. It runs in stages. Phase I funds a short feasibility study. Phase II funds the larger research and development effort, and normally only firms that have shown promise in Phase I can compete for it. Phase III is commercialization, which has to be paid for from sources other than the SBIR set-aside.
That structure makes a Phase II award a useful signal. A technical reviewer at an agency has already looked at the work twice, the money is non-dilutive, and the company has usually reached the point where it needs a commercial partner or private capital to go further.
Award records versus company records
GAO identified 6,865 businesses that received Phase II awards across all participating agencies from fiscal years 2011 through 2020, which is the basis of the figure on this page. It covers SBIR and STTR together and stops at 2020, so firms funded only after that are extra. NSF counts of firms receiving Phase II awards in a single year rose from 1,171 in 2012 to 1,870 in 2022.
Federal award data is published one award at a time, and a single company can hold several awards from different agencies under slightly different name spellings. For a sourcing team the useful unit is the company: how many Phase II awards it has won, from which agencies, and on which subjects. The concentration is real. A National Academies review of the Department of Defense program counted 3,807 unique firms with DoD Phase II SBIR/STTR awards between FY2012 and FY2023, and roughly 70 percent of them had no more than two awards in those twelve years. The rest are repeat winners, and the two groups call for different conversations.
How to read the agencies
| Agency type | What an award usually indicates |
|---|---|
| Defense | A technology with a named government customer and a possible route to procurement |
| Health | Biomedical research that may still face a long clinical and regulatory path |
| Energy and science agencies | Early hard technology, often tied to national laboratories or universities |
| Standards and measurement agencies | Smaller awards in measurement, materials, quantum and security tools |
Practical points when qualifying a company
- Separate SBIR from STTR. STTR requires a formal research institution partner, which changes where the intellectual property and the key staff may sit.
- Look at the sequence of awards. A firm that moves from Phase II into private revenue is different from one that lives on successive government awards.
- Check eligibility limits before an investment. Program rules cap firm size and limit majority ownership by venture funds, and agencies differ in how they apply this, so a financing can affect future eligibility.
- Read the award title and abstract, not only the agency. The same agency funds very different technology readiness levels.
Award size varies widely by agency. NIST Phase II awards for FY2025, for example, are in the hundreds of thousands of dollars, while defense and health awards can run far higher, so a raw award count says little without the amounts beside it.